Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma Statistics

Total Valuation

PPCB has a market cap or net worth of $1.92 million. The enterprise value is $2.01 million.

Market Cap	1.92M
Enterprise Value	2.01M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

PPCB has 15.09 million shares outstanding.

Current Share Class	15.86M
Shares Outstanding	15.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+8.34%
Owned by Insiders (%)	52.70%
Owned by Institutions (%)	3.96%
Float	7.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.16
P/TBV Ratio	0.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.06.

Current Ratio	2.13
Quick Ratio	0.16
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-90.02

Financial Efficiency

Return on equity (ROE) is -1,811.69% and return on invested capital (ROIC) is -889.20%.

Return on Equity (ROE)	-1,811.69%
Return on Assets (ROA)	-535.73%
Return on Invested Capital (ROIC)	-889.20%
Return on Capital Employed (ROCE)	-566.72%
Weighted Average Cost of Capital (WACC)	39.73%
Revenue Per Employee	n/a
Profits Per Employee	-$33.50M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.12% in the last 52 weeks. The beta is 3.48, so PPCB's price volatility has been higher than the market average.

Beta (5Y)	3.48
52-Week Price Change	-98.12%
50-Day Moving Average	0.27
200-Day Moving Average	2.23
Relative Strength Index (RSI)	27.03
Average Volume (20 Days)	1,819,246

Short Selling Information

The latest short interest is 248,625, so 1.65% of the outstanding shares have been sold short.

Short Interest	248,625
Short Previous Month	338,451
Short % of Shares Out	1.65%
Short % of Float	3.31%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-65.10M
Pretax Income	-66.07M
Net Income	-67.00M
EBITDA	-65.10M
EBIT	-65.10M
Earnings Per Share (EPS)	-$6.45

Balance Sheet

The company has $561,237 in cash and $649,216 in debt, with a net cash position of -$87,979 or -$0.01 per share.

Cash & Cash Equivalents	561,237
Total Debt	649,216
Net Cash	-87,979
Net Cash Per Share	-$0.01
Equity (Book Value)	11.45M
Book Value Per Share	0.78
Working Capital	4.08M

Cash Flow

In the last 12 months, operating cash flow was -$3.13 million and capital expenditures -$4,758, giving a free cash flow of -$3.13 million.

Operating Cash Flow	-3.13M
Capital Expenditures	-4,758
Free Cash Flow	-3.13M
FCF Per Share	-$0.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PPCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3,490.33%
FCF Yield	-163.13%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	1:59,880.24

Scores

Altman Z-Score	n/a
Piotroski F-Score	2